Roth Capital Initiates Coverage On Rapid Micro Biosystems with Buy Rating, Announces Price Target of $3

Roth Capital analyst Max Masucci has initiated coverage on Rapid Micro Biosystems (NASDAQ: RPID) with a Buy rating. The firm has set a price target of $3 for the company's stock.